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Drew Linardi RN BSN
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Introduction
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•

The topic I have chosen for my
poster presentation is type II
diabetes mellitus: a case of beta cell
underproduction and insulin
resistance (Kahn, Cooper, & Del
Prato, 2014).
The rationale for selecting this
topic was to clearly illustrate the
pathophysiological process of type
II diabetes mellitus as well as the
negative impact hyperglycemia has
on clinical outcomes (Kahn et al.,
2014).
I was personally motivated in
selecting this topic as I am a type I
diabetic patient who contracted my
condition via a viral infection from
a bee sting. I have been personally
blessed with a fantastic
endocrinologist whom together
keeps my A1C level in the mid to
upper five range.
Working in a cardiac recovery unit,
patients are frequently observed
having poor or worsening
cardiovascular and vascular
outcomes due to uncontrolled type
II diabetes.
Type II diabetes presents itself in
one of two ways (Kahn et al.,
2014). First, beta cells within the
pancreas are unable to produce
adequate amounts of insulin to
keep blood glucose levels regulated
(Kahn et al., 2014). Second, insulin
resistance occurs where
individuals who are typically
overweight or obese have been
producing too much insulin due to
lessened sensitivity in appropriate
cells (Kahn et al., 2014). Eventually
the beta cells cannot keep up the
excess insulin production and
production declines despite there
being an increased demand for it
(Kahn et al., 2014).
As of 2014, it was estimated that
29 million individuals in the United
States were diabetic with an
additional 86 million afflicted with
prediabetes (“CDC,” 2014).
A diagnosis of type II diabetes is
made when a patient has two
separate tests indicating an A1C of
6.5 or higher (“MayoClinic,” 2018).
Treatment of type II diabetes
includes weight loss, proper diet,
exercise, possible medication and
insulin therapy, and frequent blood
glucose monitoring (“MayoClinic,”
2018).

Signs & Symptoms
•

•

•

Signs and symptoms of type II
diabetes include increased thirst,
increased hunger, dry mouth,
frequent urination, unexplained
weight loss, fatigue, blurred vision,
numbness or tingling in the hands
or feet, dry and itchy skin, and slow
healing of cuts and sores
(“Cleveland Clinic, “ 2018).
Type II diabetics can go into
diabetic ketoacidosis exhibiting
signs such as fruity breath however
this is less likely to occur compared
to type I diabetics (“Medline Plus, “
2018). Diabetic ketoacidosis is
typically less severe in type II
diabetics (“Medline Plus, “2018).
Diabetic ketoacidosis is brought on
in type II diabetics by medication
noncompliance, or onset of
infection, resulting in sustained
uncontrolled hyperglycemia
(“Medline Plus,” 2018).
Long term effects of uncontrolled
type II diabetes include
retinopathy, neuropathy,
nephropathy, elevated coronary
artery disease risk, elevated
cerebrovascular disease risk, and
elevated peripheral arterial disease
risk (“Johns Hopkins Medicine, “
2018).

Patient
Presentation
Mr. R is a 59 year old
Hispanic-American male
presenting to the health
clinic with complaints of
fatigue, thirst, and
increased appetite times
three weeks despite
eating, drinking, and
sleeping more than usual.
Upon a complete history
and physical examination
Mr. R is diagnosed with
type II diabetes. Mr. R is
obese with a BMI of 32,
hypertensive with a BP of
172/104, has a sedentary
lifestyle, accucheck of 262,
and a HGA1c of 10.3
(“NIDDK,” 2018).

•

•

Pathophysiology of Type II Diabetes Mellitus
and Insulin Resistance.
Type II diabetes mellitus and insulin
resistance are complex intertwined
conditions that involve some form of
eight different pathophysiological
abnormalities (Cersosimo, Triplitt, SolisHerrera, Mandarino, and DeFronzo,
2018).
These eight mechanisms include
decreased peripheral glucose uptake in
mainly muscle combined with altered
endogenous glucose production,
increased free fatty acid lipolysis
contributing to elevated glucose output, a
reduction in peripheral glucose
utilization combined with beta cell
dysfunction (Cersosimo et al., 2018).

Beta cells at first are able to increase
insulin production but eventually are
unable to keep up with the elevated
demand (Cersosimo et al., 2018). At the
same time, an inappropriate release of
glucagon from the alpha cells of the
pancreas occurs post-prandially
(Cersosimo et al., 2018). The combination
of impaired insulin production and
elevated glucagon secretion is known as the
decreased incretin effect occurring in the
gastrointestinal tract (Cersosimo et al.,
2018). The central nervous system also
plays a major role in type II diabetes as the
hypothalamus contributes to insulin
resistance by impairing insulin’s capacity to
suppress glucose production (Cersosimo et
al., 2018).

Risk Factors
•

•

Mr. R has several risk
factors including obesity,
hypertension, age,
Hispanic ethnicity, and a
sedentary lifestyle
(‘NIDDK,’ 2018).
A definitive diagnosis of
type II diabetes can be
made after Mr. R’s
HGBA1c registers at 10.3
and his fingerstick shows
a blood glucose of 253
(Accu-Check,” 2018).

Figure 2 Ominous Octet and Hyperglycemia (Cersosimo et
al., 2018).

Pathophysiology continued.
These pathological mechanisms are
more commonly known as the ominous
octet leading to hyperglycemia in type II
diabetes depicted above in figure 2
(Cersosimo et al., 2018).
In insulin resistance the kidneys
increase rates of glucose reabsorption at
times to levels of 220 to 250 mg/dl before
reaching a maximum reabsorptive
capacity (Cersosimo et al., 2018).
Once reabsorptive capacity is reached
elevated blood glucose occurs in
peripheral circulation (Cersosimo et al.,
2018).
Figure 1 Type II Diabetes Symptoms & Warning Signs (Lupo D.C., 2018).

The liver plays a major role in glucose
regulation as it is the main organ
responsible for glucose uptake after meal
consumption (Cersosimo et al., 2018).
Individuals afflicted with type II
diabetes have reduced hepatic glucose
uptake post-prandially resulting in elevated
blood glucose levels (Cersosimo et al.,
2018).

o
Significance of
Pathophysiology.
With an increasingly overweight and
obese population insulin resistance I
becoming more commonplace (Kahn et
al., 2014).
Insulin resistance and obesity often
times go hand in hand when it comes to
type II diabetes (Kahn et al., 2014). There
is a feedback loop that exists between
beta cells and insulin sensitive tissues
(Kahn et al., 2014).
Insulin released by the beta cells
facilitates the uptake of glucose, fatty
acids, and amino acids (Kahn et al.,
2014).
The tissue of overweight and obese
individuals becomes less sensitive to
insulin increasing the demand on the
beta cells to produce greater amounts of
insulin to maintain normal blood glucose
levels (Kahn et al., 2014).
Over time the beta cells fatigue and
can no longer keep up with the
increased demand for insulin production
resulting in hyperglycemia (Kahn et al.,
2014). This is a frequent occurrence in
obese and overweight individuals which
can be rectified with weight loss (Kahn et
al., 2014).
As of 2018, nearly 70% of Americans
are either overweight or obese (“AHA,”
2018).
Obesity is defines as being at or
greater than 20% of an individuals ideal
weight (“AHA,” 2018).
Currently there are nearly 13 million
children ages 2-19 who are obese with
an additional 11 million classified as
overweight (“AHA,” 2018).
The figures yield a total of 23.9
million children qualifying as either
overweight or obese (‘AHA, “ 2018).
Roughly 35% of adults in the United
States qualify as obese totaling 78 million
individuals (“AHA, “ 2018).
Individuals qualifying as overweight
or obese are at increased risk of
developing diabetes, heart disease,
hypertension, and stroke (“AHA, “ 2018).
As healthcare evolves to a primary
prevention based focus individuals will
need counseling regarding ideal body
weight, portion control, prevention of
obesity, as well as the risks of
concomitant conditions such as diabetes
and heart disease ( Macha & McDonough,
2012).

Implications for Care.
A study was conducted evaluating
patients undergoing noncardiac surgery
from the years 2004 to 2013
encompassing roughly 10.5 million
individuals (Newman, Wilcox, Smilowitz,
and Berger, 2018).
The study evaluated MACCE
outcomes in diabetic patients versus
nondiabetic patients (Newman et al.,
2018). MACCE outcomes where defined
as major adverse cardiovascular and
cerebrovascular events (Newman et al.,
2018).
The study found that diabetic
patients exhibited a statistically
significant increased likelihood of
experiencing a MACCE event including all
cause mortality, myocardial infarction,
and ischemic stroke versus nondiabetic
patients (Newman et al., 2018).
The increased risk of MACCE events
in diabetic patients was supported with a
p value of <0.001 (Newman et al., 2018).
The study found that from 2004 to 2013
the amount of diabetic patients
presenting for surgery had increased
significantly from the studies inception
(Newman et al., 2018).
Rehman and others found that
patients presenting with ischemic stroke
were more often found to have
hyperglycemia and raised hemoglobin
A1C than not (Rehman, Alam, & Rehman,
2017).

Conclusion
Hayward and others conducted a
study evaluating 1,791 military veterans
with type II diabetes and randomly
assigned half the subjects to intensive
glucose control and the other half to
standard therapy (Hayward et al., 2015).
The results revealed that individuals
in the intensive glucose therapy group
experienced significantly fewer major
cardiovascular events than those
assigned to the standard therapy group
(Hayward et al., 2015).
Current projections have shown that
by the year 2030 roughly 552 million
individuals will have diabetes (Laakso &
Kuusisto, 2014).
As healthcare providers, it is
imperative to reverse this trend and limit
the micro and macrovascular
complications of type II diabetes and
insulin resistance (Laakso & Kuusisto.,
2014).
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